Comparative Outcomes of Primary, Recurrent, and Progressive High-risk Non–muscle-invasive Bladder Cancer
Author:
Publisher
Elsevier BV
Subject
Urology
Reference16 articles.
1. Global cancer statistics;Jemal;CA Cancer J Clin,2011
2. Economic aspects of bladder cancer: what are the benefits and costs?;Sievert;World J Urol,2009
3. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials;Sylvester;Eur Urol,2006
4. MicroRNA in prostate, bladder, and kidney cancer: a systematic review;Catto;Eur Urol,2011
5. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update;Babjuk;Eur Urol,2011
Cited by 67 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Why is it necessary to produce a BCG strain in Spain?;Actas Urológicas Españolas (English Edition);2024-09
2. ¿Por qué es necesario tener una cepa de BCG fabricada en España?;Actas Urológicas Españolas;2024-09
3. Assessing the Predictive Accuracy of EORTC, CUETO and EAU Risk Stratification Models for High-Grade Recurrence and Progression after Bacillus Calmette–Guérin Therapy in Non-Muscle-Invasive Bladder Cancer;Cancers;2024-04-26
4. Bladder tumor Resection Weight as a Prognostic Factor for Recurrence and Progression in Patients With High-Risk Non-Muscle Invasive Bladder Treated With BCG;Clinical Genitourinary Cancer;2023-04
5. Impact of COVID-19 on Uro-Oncological Patients: A Comprehensive Review of the Literature;Microorganisms;2023-01-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3